Continuous coverage unwinding
Jun. 2023Important Notices
The continuous coverage unwinding period began on April 1. Medicaid recipients may have questions about their Medicaid eligibility determination.
We developed this FAQ to help you educate patients who have already submitted their renewal.
The goal of this material is to:
We developed this FAQ to help you educate patients who have already submitted their renewal.
The goal of this material is to:
- Help patients understand the Medicaid renewal process and have them keep an eye out for mail from DHS.
- Provide guidance to patients who did not return required verification documents.
- Provide guidance to patients who received a coverage termination letter.
- UPMC for You Continuous Coverage Postcard
- UPMC for You Continuous Coverage Postcard Spanish
- UPMC Community HealthChoices Participant Postcard
- UPMC Community HealthChoices Participant Postcard Spanish
In addition to the FAQ, the items below may be distributed to your UPMC for You patients and UPMC Community HealthChoices participants. These materials can be ordered through MarketingExpress, which is available via Provider OnLine.
Instructions on how to use MarketingExpress are also available. If you have any questions, please contact your physician account executive or call Provider Services at 1-866-918-1595.
Recent Announcements
CME Webinar: The State of Telehealth in 2026
Please join us for a live, CME-accredited webinar on Tuesday, Jan. 27, from noon to 1 p.m. that will share updates on the state of telehealth for 2026.Dec. 2025Education/Webinars
Formulary updates effective Jan. 1, 2026
Review upcoming policy and operational updatesDec. 2025Pharmacy Updates
Voluntary nationwide recall: Famotidine (Fresenius – November)
Fresenius Kabi USA, LLC is recalling three lots (6133156, 6133194, and 6133388) of Famotidine Injection, USP, 20 mg per 2 mL. Famotidine is used to treat excessive secretion of stomach acid or stomach ulcers.Nov. 2025Pharmacy Updates